Section editor's notebook: Breast cancer screening and overdiagnosis unmasked

American Journal of Roentgenology

Volumn 202, Issue 2, 2014, Pages 259-261

  Javitt, Marcia C ^a  

^a University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ERROR; DIGITAL MAMMOGRAPHY; ECHOMAMMOGRAPHY; EDITORIAL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED BIOPSY; INTRADUCTAL CARCINOMA; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOMOSYNTHESIS; TUMOR INVASION; UNITED STATES;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; RADIATION DOSAGE; RISK FACTORS;

EID: 84892771644     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.12052     Document Type: Editorial

References (43)

1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737
2. American Cancer Society website. Cancer facts and figures 2013. www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/ acspc-036845.pdf. Accessed May 8, 2013
3. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19(suppl 1):42-56
4. Paci E, Broeders M, Hofvind S, et al. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012;19(suppl 1):5-13
5. Yen MF, Tabár L, Vitak B, et al. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003; 39:1746-1754
6. Duffy SW, Agbaje O, Tabár L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005; 7:258-265
7. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011; 12:21-29
8. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004; 328:921-924
9. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009; 339:b2587
10. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367:1998-2005
11. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009; 151:738-747
12. de Roos MA, van der Vegt B, de Vries J, et al. Pathological and biological differences between screendetected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 2007; 14:2097-2104
13. Matson S, Andersson I, Berglund G, et al. Non-attendance in mammographic screening: a study of intra-urban differences from the city of Malmö in Sweden 1990-94. Cancer Detect Prev 2001; 25:132-137
14. Zackrisson S, Andersson I, Manjer J, et al. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004; 108:754-760
15. Duffy SW, Tabár L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17:25-30
16. Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95:458-469
17. Zackrisson S, Andersson I, Janzon L, et al. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006; 332:689-692
18. Olsen AH, Agbaje OF, Myles JP, et al. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006; 12:338-342
19. Puliti D, Zappa M, Miccinesi G, et al. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009; 45:3166-3171
20. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the Science Conference statement: diagnosis and management of ductal carcinoma in situ - September 22-24, 2009. J Natl Cancer Inst 2010; 102:161-169
21. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997; 127:1023-1028
22. Nielsen M, Thomsen JL, Primdahl S, et al. Breast cancer and atypia among young and middle-aged women: a study of 100 medicolegal biopsies. Br J Cancer 1987; 56:814-819
23. Kopans DB, Smith RA, Duffy SW. Mammographic screening and "overdiagnosis." Radiology 2011; 260:616-620
24. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography. I. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006; 15:45-51
25. Tabár L, Vitak B, Chen HH, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91:1724-1731
26. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011; 117:714-722
27. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003; 361:1411-1417
28. Smith RA, Duffy SW, Tabár L. Breast cancer screening: the evolving evidence. Oncology 2012; 26:471-475
29. Shapiro S, Venet W, Strax P, et al. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69:349-355
30. Shapiro S. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963-1986. Baltimore, MD: Johns Hopkins University Press, 1988
31. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297:943-948
32. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341:973-978
33. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359:909-919
34. Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 325:829-832
35. Tabár L, Fagerberg G, Duffy SW, et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30:187-210
36. Tabár L, Fagerberg G, Duffy SW, et al. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-114
37. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990; 335:241-246
38. Miller AB, To T, Baines CJ, et al. The Canadian National Breast Screening Study. 1. Breast cancer mortality after 11 to 16 years of follow-up: a randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305-312
39. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study. 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147:1477-1488
40. Frisell J, Eklund G, Hellström L, et al. Randomized study of mammography screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18:49-56
41. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006;368:2053-2060
42. Smith RA, Duffy S, Tabár L. Screening and early detection. In: Barbiera GV, Esteva FJ, Skoracki R, eds. Advanced therapy of breast disease, 3rd ed. Shelton, CT: People's Medical Publishing House, 2011
43. Humphrey LL, Helfand M, Chan BK, et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347-360